Drug Approval | January 31, 2024
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Subscribe To Our Newsletter & Stay Updated
